Skip to main content
SKIN
NASDAQ Industrial Applications And Services

SkinHealth Systems Inc. Terminates Chief Revenue Officer Ronald Menezes

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$0.933
Mkt Cap
$120.863M
52W Low
$0.757
52W High
$2.69
52W Position info
23% above low
Off High info
65% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SKIN sits 23% above its 52-week low of $0.757.

Summary

SkinHealth Systems Inc. announced the termination of its Chief Revenue Officer, Ronald Menezes, effective May 5, 2026, without cause.


Key Events · Executive and Board Changes · SKIN

  • Chief Revenue Officer Terminated

    Mr. Ronald Menezes' employment as Chief Revenue Officer was terminated by the Board of Directors, effective May 5, 2026.

  • Termination Without Cause

    The termination was stated to be 'without cause' and not a result of any disagreement with the company's financial reporting, operations, policies, or practices.

  • Separation Agreement Pending

    The company intends to enter into a separation agreement with Mr. Menezes, with material terms yet to be determined and negotiations ongoing. An amendment to the 8-K will be filed once a definitive agreement is reached.


Analysis · SKIN · Industrial Applications And Services

The termination of a Chief Revenue Officer, a key executive responsible for driving sales and growth, introduces uncertainty regarding the company's future revenue strategy and execution. While the company stated the termination was 'without cause' and not due to disagreements on financial reporting or operations, the departure of a C-suite member can still signal internal shifts or challenges. Investors will be watching for details on the separation agreement and the appointment of a successor to understand the long-term impact on the company's commercial efforts.

How filings like this one have moved

In the 30 days to Sep 20, 2026, 29.6% of the 1592 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SKIN was trading at $0.93 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $120.9M. The 52-week trading range was $0.76 to $2.69. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SKIN - Latest Insights

SKIN
Aug 12, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.6468
Real-time Price: $0.680425 info
Change: +$0.033625 (+5%) info
Market Cap: $87.845M info
SKIN
Aug 06, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.693
Real-time Price: $0.680425 info
Change: -$0.012575 (-2%) info
Market Cap: $87.845M info
SKIN
Aug 06, 2026, 4:43 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.677
Real-time Price: $0.680425 info
Change: +$0.003425 (+0.51%) info
Market Cap: $87.845M info
SKIN
Aug 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6776
Real-time Price: $0.680425 info
Change: +$0.002825 (+0.42%) info
Market Cap: $87.845M info
SKIN
Jul 31, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.6855
Real-time Price: $0.680425 info
Change: -$0.005075 (-0.74%) info
Market Cap: $87.845M info